Scholar Rock Reports First Quarter 2023 Financial Results and Highlights Business Progress

Author's Avatar
May 09, 2023

Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today reported financial results and corporate updates for the first quarter ended March 31, 2023.